FIBROGEN (FGEN) Covered Calls

FibroGen Inc is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

You can sell covered calls on FIBROGEN to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for FGEN (prices last updated Mon 4:16 PM ET):

FIBROGEN (FGEN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
50.60 -2.30 49.81 63.00 496K - 4.5B
Covered Calls For FIBROGEN (FGEN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 50 3.30 59.70 -16.2% -227.4%
Dec 21 50 5.50 57.50 -13.0% -77.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

FibroGen, Inc. operates as a research-based biopharmaceutical company that engages in the discovery, development and commercialization of therapeutics to treat unmet medical needs. It focuses on its experience in fibrosis and hypoxia-induced factor biology to generate multiple programs targeting various therapeutic areas. The company product candidate are roxadustat, or FG-4592, is an oral small molecule inhibitor of HIF prolyl hydroxylases, or HIF-PHs, in Phase 3 clinical development for the treatment of anemia in chronic kidney disease, or CKD. FibroGen was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.